Cargando…
Genome deletions to overcome the directed loss of gene function in Leishmania
With the global reach of the Neglected Tropical Disease leishmaniasis increasing, coupled with a tiny armory of therapeutics which all have problems with resistance, cost, toxicity and/or administration, the validation of new drug targets in the causative insect vector borne protozoa Leishmania spp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539739/ https://www.ncbi.nlm.nih.gov/pubmed/36211960 http://dx.doi.org/10.3389/fcimb.2022.988688 |
_version_ | 1784803554833203200 |
---|---|
author | Alpizar-Sosa, Edubiel A. Kumordzi, Yasmine Wei, Wenbin Whitfield, Phillip D. Barrett, Michael P. Denny, Paul W. |
author_facet | Alpizar-Sosa, Edubiel A. Kumordzi, Yasmine Wei, Wenbin Whitfield, Phillip D. Barrett, Michael P. Denny, Paul W. |
author_sort | Alpizar-Sosa, Edubiel A. |
collection | PubMed |
description | With the global reach of the Neglected Tropical Disease leishmaniasis increasing, coupled with a tiny armory of therapeutics which all have problems with resistance, cost, toxicity and/or administration, the validation of new drug targets in the causative insect vector borne protozoa Leishmania spp is more important than ever. Before the introduction of CRISPR Cas9 technology in 2015 genetic validation of new targets was carried out largely by targeted gene knockout through homologous recombination, with the majority of genes targeted (~70%) deemed non-essential. In this study we exploit the ready availability of whole genome sequencing technology to reanalyze one of these historic cell lines, a L. major knockout in the catalytic subunit of serine palmitoyltransferase (LCB2), which causes a complete loss of sphingolipid biosynthesis but remains viable and infective. This revealed a number of Single Nucleotide Polymorphisms, but also the complete loss of several coding regions including a gene encoding a putative ABC3A orthologue, a putative sterol transporter. Hypothesizing that the loss of such a transporter may have facilitated the directed knockout of the catalytic subunit of LCB2 and the complete loss of de novo sphingolipid biosynthesis, we re-examined LCB2 in a L. mexicana line engineered for straightforward CRISPR Cas9 directed manipulation. Strikingly, LCB2 could not be knocked out indicating essentiality. However, simultaneous deletion of LCB2 and the putative ABC3A was possible. This indicated that the loss of the putative ABC3A facilitated the loss of sphingolipid biosynthesis in Leishmania, and suggested that we should re-examine the many other Leishmania knockout lines where genes were deemed non-essential. |
format | Online Article Text |
id | pubmed-9539739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95397392022-10-08 Genome deletions to overcome the directed loss of gene function in Leishmania Alpizar-Sosa, Edubiel A. Kumordzi, Yasmine Wei, Wenbin Whitfield, Phillip D. Barrett, Michael P. Denny, Paul W. Front Cell Infect Microbiol Cellular and Infection Microbiology With the global reach of the Neglected Tropical Disease leishmaniasis increasing, coupled with a tiny armory of therapeutics which all have problems with resistance, cost, toxicity and/or administration, the validation of new drug targets in the causative insect vector borne protozoa Leishmania spp is more important than ever. Before the introduction of CRISPR Cas9 technology in 2015 genetic validation of new targets was carried out largely by targeted gene knockout through homologous recombination, with the majority of genes targeted (~70%) deemed non-essential. In this study we exploit the ready availability of whole genome sequencing technology to reanalyze one of these historic cell lines, a L. major knockout in the catalytic subunit of serine palmitoyltransferase (LCB2), which causes a complete loss of sphingolipid biosynthesis but remains viable and infective. This revealed a number of Single Nucleotide Polymorphisms, but also the complete loss of several coding regions including a gene encoding a putative ABC3A orthologue, a putative sterol transporter. Hypothesizing that the loss of such a transporter may have facilitated the directed knockout of the catalytic subunit of LCB2 and the complete loss of de novo sphingolipid biosynthesis, we re-examined LCB2 in a L. mexicana line engineered for straightforward CRISPR Cas9 directed manipulation. Strikingly, LCB2 could not be knocked out indicating essentiality. However, simultaneous deletion of LCB2 and the putative ABC3A was possible. This indicated that the loss of the putative ABC3A facilitated the loss of sphingolipid biosynthesis in Leishmania, and suggested that we should re-examine the many other Leishmania knockout lines where genes were deemed non-essential. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9539739/ /pubmed/36211960 http://dx.doi.org/10.3389/fcimb.2022.988688 Text en Copyright © 2022 Alpizar-Sosa, Kumordzi, Wei, Whitfield, Barrett and Denny https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Alpizar-Sosa, Edubiel A. Kumordzi, Yasmine Wei, Wenbin Whitfield, Phillip D. Barrett, Michael P. Denny, Paul W. Genome deletions to overcome the directed loss of gene function in Leishmania |
title | Genome deletions to overcome the directed loss of gene function in Leishmania
|
title_full | Genome deletions to overcome the directed loss of gene function in Leishmania
|
title_fullStr | Genome deletions to overcome the directed loss of gene function in Leishmania
|
title_full_unstemmed | Genome deletions to overcome the directed loss of gene function in Leishmania
|
title_short | Genome deletions to overcome the directed loss of gene function in Leishmania
|
title_sort | genome deletions to overcome the directed loss of gene function in leishmania |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539739/ https://www.ncbi.nlm.nih.gov/pubmed/36211960 http://dx.doi.org/10.3389/fcimb.2022.988688 |
work_keys_str_mv | AT alpizarsosaedubiela genomedeletionstoovercomethedirectedlossofgenefunctioninleishmania AT kumordziyasmine genomedeletionstoovercomethedirectedlossofgenefunctioninleishmania AT weiwenbin genomedeletionstoovercomethedirectedlossofgenefunctioninleishmania AT whitfieldphillipd genomedeletionstoovercomethedirectedlossofgenefunctioninleishmania AT barrettmichaelp genomedeletionstoovercomethedirectedlossofgenefunctioninleishmania AT dennypaulw genomedeletionstoovercomethedirectedlossofgenefunctioninleishmania |